Investegate |atai Life Sciences Announcements | atai Life Sciences: atai Life Sciences Announces R&D Day Agenda
Investegate announcements from atai Life Sciences, atai Life Sciences Announces R&D Day Agenda
Stay updated with breaking news from Program Updates. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investegate announcements from atai Life Sciences, atai Life Sciences Announces R&D Day Agenda
The turboprop line now flies out of the factory on sustainable aviation fuel, with eco-challenge features incorporated into the Me & My TBM app.
16.08.2022 - On track to file New Drug Application for Renazorb, the first proprietary nanoparticle-based phosphate binder for Chronic Kidney Disease (CKD) patients, by end of 2023 Signed first global partnership for rights to Renazorb in China with Lee’s ...
Strong balance sheet of ~$324 million cash, cash equivalents and marketable securities as of June 30, 2022 is anticipated to fund planned operatio...
/PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform...